MHRA warns over students using ‘smart drugs’

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a statement warning university students of the dangers of taking prescription ’smart’ medicines to get higher marks.

The announcement comes as new research from the Agency found 14 per cent of those surveyed were likely to purchase so-called ‘smart dugs’ within the next year.

Such medicines include Modafinil and Ritalin, which is used to treat ADHD.

Possible side effects from self-medicating these substances can include risk of dependence, cardiovascular problems and psychosis.

Lynda Scammell, MHRA Senior Policy Manager, warned: “You may be offered ‘smart drugs’ or ‘cognitive enhancers’ at university – some of them may be potent medicines which should only be prescribed by a doctor.

“Modafinil is licensed for specific medical conditions – not for use as a ‘boost’ during exams. Don’t put your health at risk by self-medication - it could have serious side effects.

“It’s a criminal offence to supply prescription only medicines without a valid prescription - websites offering them are acting illegally.

“Be smart – don’t put your health at risk by buying medicines online and don’t give your student loan to a criminal.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho